A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)

Clinical trial NCT06730061 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06730061
Sponsor: Ipsen
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Biliary Cholangitis

Start date: 2025-01-16
Primary completion: 2026-12-17
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.